Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Operating Leases (2020 - 2026)

Alvotech's (ALVO) quarterly Operating Leases came in at $134.0 million in Q2 2026, down 1.69% on a YoY basis from $136.3 million in Q2 2025, and little changed quarter-over-quarter from $134.5 million in Q1 2026.

Analysis

Alvotech (ALVO) Operating Leases (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Operating Leases for 7 consecutive years, with $134.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Leases fell 1.69% year-over-year to $134.0 million; the trailing twelve-month figure through Jun 2026 stood at $134.0 million (down 1.69% YoY), and the FY2025 full-year result was $138.0 million, up 23.06% from the prior year.
  • Operating Leases steadied at $134.0 million in Q2 2026 per ALVO's latest filing, from $134.5 million in the prior quarter.
  • Across five years, Operating Leases topped out at $144.5 million in Q3 2025 and bottomed at $40.5 million in Q4 2022.
  • Historically, Operating Leases has averaged $118.5 million across 5 years, with a median of $120.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Operating Leases slumped 66.82% in 2022, then soared 184.5% in 2023.
  • Over 5 years, Operating Leases stood at $40.5 million in 2022, then jumped by 184.5% to $115.3 million in 2023, then fell by 2.76% to $112.1 million in 2024, then rose by 23.06% to $138.0 million in 2025, then dropped by 2.93% to $134.0 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $134.0 million, $134.5 million, and $138.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 133.96 Mn
Mar 31, 2026 134.52 Mn
Dec 31, 2025 138.00 Mn
Sep 30, 2025 144.52 Mn
Jun 30, 2025 136.26 Mn
Mar 31, 2025 119.15 Mn
Dec 31, 2024 112.14 Mn
Sep 30, 2024 140.76 Mn
Jun 30, 2024 121.87 Mn
Mar 31, 2024 110.59 Mn
Dec 31, 2023 115.32 Mn
Jun 30, 2023 95.40 Mn
Dec 31, 2022 40.53 Mn
Jun 30, 2022 115.30 Mn
Dec 31, 2021 122.14 Mn
Dec 31, 2020 108.95 Mn